0001722024-21-000010.txt : 20211021
0001722024-21-000010.hdr.sgml : 20211021
20211021205946
ACCESSION NUMBER: 0001722024-21-000010
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211021
FILED AS OF DATE: 20211021
DATE AS OF CHANGE: 20211021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alexandria Venture Investments, LLC
CENTRAL INDEX KEY: 0001722024
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40925
FILM NUMBER: 211338479
BUSINESS ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
BUSINESS PHONE: 626-578-0777
MAIL ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xilio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840233
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851623397
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-833-1027
MAIL ADDRESS:
STREET 1: 828 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
3
1
wf-form3_163486435756876.xml
FORM 3
X0206
3
2021-10-21
0
0001840233
Xilio Therapeutics, Inc.
XLO
0001722024
Alexandria Venture Investments, LLC
26 NORTH EUCLID AVENUE
PASADENA
CA
91101
0
0
1
0
Series B convertible preferred stock
Common stock
166423.0
D
The preferred stock is convertible into the Issuer's common stock at a ratio of 9.5 shares of preferred stock to 1 share of common stock at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering, for no additional consideration.
By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member
By: /s/ Dean A. Shigenaga
Chief Financial Officer
2021-10-21